ProfileGDS4718 / 236270_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 35% 33% 70% 32% 31% 32% 24% 34% 35% 24% 30% 36% 28% 30% 30% 30% 27% 31% 39% 42% 39% 28% 30% 28% 36% 33% 26% 31% 32% 33% 31% 39% 36% 38% 36% 32% 31% 36% 30% 75% 35% 28% 39% 26% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7849435
GSM549102patient 115, normal, homogenized [OPG study]4.7074633
GSM549104patient 119, normal, homogenized [OPG study]6.9164170
GSM549108patient 138, normal, homogenized [OPG study]4.6852332
GSM549119patient 077, normal, homogenized [OPG study]4.6137231
GSM549133patient 032, cancer, homogenized [OPG study]4.5493232
GSM549139patient 042, cancer, homogenized [OPG study]4.2748124
GSM549099patient 107, normal, homogenized [OPG study]4.7367934
GSM549109patient 139, normal, homogenized [OPG study]4.7697235
GSM549110patient 046, normal, homogenized [OPG study]4.3094524
GSM549114patient 063, normal, homogenized [OPG study]4.4958530
GSM549122patient 082, normal, homogenized [OPG study]4.7988336
GSM549134patient 033, cancer, homogenized [OPG study]4.4323728
GSM549136patient 036, cancer, homogenized [OPG study]4.4617830
GSM549140patient 044, cancer, homogenized [OPG study]4.5094830
GSM549111patient 047, normal, homogenized [OPG study]4.5065630
GSM549113patient 057, normal, homogenized [OPG study]4.3732927
GSM549132patient 031, cancer, homogenized [OPG study]4.5726831
GSM549137patient 038, cancer, homogenized [OPG study]4.9345339
GSM549142patient 047, cancer, homogenized [OPG study]5.2286342
GSM549100patient 110, normal, homogenized [OPG study]4.9576739
GSM549107patient 135, normal, homogenized [OPG study]4.414628
GSM549115patient 068, normal, homogenized [OPG study]4.5028430
GSM549116patient 072, normal, homogenized [OPG study]4.4314528
GSM549120patient 078, normal, homogenized [OPG study]4.8057636
GSM549131patient 030, cancer, homogenized [OPG study]4.6260833
GSM549118patient 074, normal, homogenized [OPG study]4.3809326
GSM549129patient 027, cancer, homogenized [OPG study]4.607331
GSM549123patient 088, normal, homogenized [OPG study]4.5954332
GSM549124patient 006, cancer, homogenized [OPG study]4.7281633
GSM549126patient 015, cancer, homogenized [OPG study]4.5671731
GSM549128patient 025, cancer, homogenized [OPG study]4.9135939
GSM549103patient 117, normal, homogenized [OPG study]4.8537536
GSM549117patient 073, normal, homogenized [OPG study]4.8424938
GSM549138patient 041, cancer, homogenized [OPG study]4.7814236
GSM549141patient 045, cancer, homogenized [OPG study]4.5560232
GSM549130patient 028, cancer, homogenized [OPG study]4.6169131
GSM549101patient 111, normal, homogenized [OPG study]4.8573436
GSM549105patient 128, normal, homogenized [OPG study]4.5774930
GSM549106patient 134, normal, homogenized [OPG study]7.4139775
GSM549112patient 048, normal, homogenized [OPG study]4.746335
GSM549125patient 011, cancer, homogenized [OPG study]4.4616628
GSM549127patient 024, cancer, homogenized [OPG study]4.9281439
GSM549135patient 035, cancer, homogenized [OPG study]4.3424326